Skip to content
BYO LUX
BYO LUXBe Your Own Luxury
All Treatments
Skincare

Azelaic Acid

Naturally derived dicarboxylic acid | Brightening, anti-inflammatory, pore care

Duration
dailyのtopical (朝・夜)
Downtime
なし
Sessions
continuous (最低12 weeks間推奨)

About This Treatment

Azelaic acid is a naturally occurring C9 dicarboxylic acid found in grains (wheat, barley, rye) with multifaceted pharmacological effects in dermatology. It inhibits tyrosinase to suppress melanin production, provides antibacterial activity (particularly against Cutibacterium acnes), anti-inflammatory effects (suppressing reactive oxygen species), and normalizes keratinization.

Prescribed at 15-20% concentration in aesthetic dermatology in Japan; FDA-approved for rosacea treatment in the West. Notable for pregnancy safety (FDA Category B). Useful as alternative therapy for patients intolerant to hydroquinone or retinoids.

Mechanism of Action

Azelaic acid has multiple mechanisms: (1) Competitively inhibits tyrosinase, suppressing melanin synthesis in melanosomes (brightening). (2) Inhibits protein synthesis of aerobic and anaerobic bacteria, exerting direct antibacterial activity against C. acnes and Staphylococcus. (3) Functions as a scavenger of neutrophil-generated reactive oxygen species (ROS), suppressing inflammatory cascades. (4) Normalizes abnormal keratinization, preventing follicular occlusion (comedone formation). These multifaceted actions work synergistically for acne, hyperpigmentation, and rosacea.

Indications

AcneRedness / vascular concernsPigmentation / dullnessPores

Expected Results

Inflammatory acne reduction observed 4-8 weeks after starting 15-20% azelaic acid. Significant hyperpigmentation improvement with 12 weeks continuous use. Rosacea erythema and papules reduce at 8-12 weeks. Clinical data shows brightening efficacy comparable to 4% hydroquinone with lower irritation potential.

Clinical Evidence

Fitton A, Goa KL (1991)
Azelaic acid: a review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders. Drugs
Clinical improvement was reported in this study (see original paper for details).
Thiboutot D et al. (2003)
Efficacy and safety of azelaic acid 15% gel in the treatment of papulopustular rosacea. J Am Acad Dermatol
Clinical improvement was reported in this study (see original paper for details).
Breathnach AS (1999)
Azelaic acid: potential as a general antitumoural agent. Med Hypotheses
Clinical improvement was reported in this study (see original paper for details).
Draelos ZD et al. (2006)
A comparison of azelaic acid 20% cream and hydroquinone 4% cream for the treatment of facial hyperpigmentation. Clin Ther
Clinical improvement was reported in this study (see original paper for details).

Risks & Side Effects

Mild initial irritation (stinging, itching, burning sensation) may occur but typically subsides within 2-4 weeks. Serious adverse effects extremely rare. No ochronosis risk unlike hydroquinone, enabling long-term use. Safe during pregnancy and lactation (FDA Category B).

Interested in this treatment?

Start with an AI skin analysis to check your current skin condition

Get AI Skin AnalysisBook Now

Other Treatments

LaserPicoSure ProLearn more LaserFractional LaserLearn more LaserPhotofacial IPL (Stellar M22)Learn more Anti-AgingThermage FLXLearn more